Table 2.
Subject baseline characteristics* (Mean values and standard deviations)
| Mean | sd | MetS criteria† | Range | ||
|---|---|---|---|---|---|
| Age (years) | 49 | 11 | 24–64 | ||
| Participants with high CRP (years)‡ | 50·6 | 12·3 | 24–64 | ||
| Participants with low CRP (years)‡ | 47·9 | 9·4 | 25–57 | ||
| Weight (kg) | 90·5 | 9·5 | 66·1–109·0 | ||
| Height (m) | 1·7 | 0·1 | 1·5–1·8 | ||
| BMI (kg/m2) | 31·7 | 2·9 | 24·4–37·1 | ||
| WC (inches) | 38·7 | 2·4 | 32–42·4 | ||
| WC, males (inches)§ | 39·4 | 1·3 | >40 | 37·2–41 | |
| WC, females (inches)§ | 38·3 | 2·8 | >35 | 32–42·4 | |
| WC (cm) | 98·3 | 6·1 | 81–107·7 | ||
| WC, males (cm)§ | 100·1 | 3·3 | >102 | 94·5–104·1 | |
| WC, females (cm)§ | 97·3 | 7·1 | >89 | 81·3–107·7 | |
| Systolic BP (mmHg) | 127 | 14·1 | ≥130 | 98–151·5 | |
| Diastolic BP (mmHg) | 78·1 | 9 | ≥85 | 57–98·5 | |
| HDL-cholesterol | |||||
| mg/dl | 45·9 | 9·7 | 31–60 | ||
| mmol/l | 1·19 | 0·25 | 0·80–1·55 | ||
| HDL-cholesterol, male§ | |||||
| mg/dl | 41·9 | 10·3 | <40 | 31–56 | |
| mmol/l | 1·08 | 0·27 | <1·03 | 0·80–1·45 | |
| HDL-cholesterol, female§ | |||||
| mg/dl | 48·1 | 9·0 | <50 | 33–60 | |
| mmol/l | 1·24 | 0·23 | <1·29 | 0·85–1·55 | |
| Fasting glucose | |||||
| mg/dl | 91·8 | 7·4 | ≥100 | 78–104 | |
| mmol/l | 5·1 | 0·4 | ≥5·6 | 4·3–5·8 | |
| Fasting TAG | |||||
| mg/dl | 124·4 | 45·7 | ≥150 | 65–224 | |
| mmol/l | 1·40 | 0·52 | ≥1·69 | 0·73–2·53 | |
MetS, metabolic syndrome; CRP, C-reactive protein; WC, waist circumference; BP, blood pressure.
*
Measurements taken at screening visit (n 20).
†
MetS as defined by the American Heart Associations.
‡
High baseline CRP n 10; low baseline CRP n 10.
§
Male n 7; female n 13.